Delivery Order SPE2DB22D2206-SPE2DB25FJG53
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,108.90 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams), with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers, with a ceiling value of $3,278.52. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 13, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,169.18 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 mcg inhalant medication (12 gram units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Fluticasone Propionate HFA 220 micrograms in a 12-gram inhaler. This firm fixed-price delivery order, valued at $4,297.53, is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The award carries no set-aside designation, indicating...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $2,532.00 delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 mcg inhalers (12 grams). This competitively awarded, firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a standard pharmaceutical procurement under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Fluticasone Propionate HFA 44 mcg 10.6gm inhalers, valued at $1,257.22. This is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,831.71 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 MCG inhalers (12 grams) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply delivery under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Fluticasone Propionate HFA 220 micrograms in a 12-gram inhaler. This competitively awarded, non-set-aside contract carries a ceiling value of $3,753.01 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,715.83 on July 29, 2025, for the supply of Fluticasone Propionate HFA 44 microgram inhalers (10.6 grams). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $4,535.86 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 220 MCG inhalers (12 grams). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJG53Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,803.08 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Fluticasone Propionate HFA 220 mcg inhalers (12 grams). This non-competitive, firm fixed-price delivery order is scheduled for completion by August 7, 2025, with performance based in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical supplier to federal medical procurement needs, particularly within the military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp has demonstrated consistent capability in fulfilling federal medical supply requirements through competitive procurement processes, making it a significant vendor within the Defense Logistics Agency's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/6/25 |